Literature DB >> 24337150

[DRESS syndrome following sulfasalazine treatment].

M Pirklbauer1, J Gruber.   

Abstract

A female patient developed systemic rash, lung edema, electrocardiogram (ECG) abnormalities and fulminant hepatitis with partial liver failure 4 weeks after the start of sulfasalazine treatment. Peripheral T-cell activation, a positive PCR test for human herpesvirus (HHV) 6 as well as eosinophilia in bronchial lavage and a differential blood count were also present. After initiation of systemic corticosteroid therapy and cessation of accompanying medication the clinical symptoms and abnormal laboratory test levels were gradually resolved. A DRESS syndrome (drug rash with eosinophilia and systemic symptoms) was confirmed in accordance with the diagnostic criteria.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24337150     DOI: 10.1007/s00393-013-1308-5

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  4 in total

1.  The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations.

Authors:  T Shiohara; M Iijima; Z Ikezawa; K Hashimoto
Journal:  Br J Dermatol       Date:  2007-03-23       Impact factor: 9.302

2.  Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response.

Authors:  Damien Picard; Baptiste Janela; Vincent Descamps; Michel D'Incan; Philippe Courville; Serge Jacquot; Sylvie Rogez; Laurent Mardivirin; Hélène Moins-Teisserenc; Antoine Toubert; Jacques Benichou; Pascal Joly; Philippe Musette
Journal:  Sci Transl Med       Date:  2010-08-25       Impact factor: 17.956

Review 3.  Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS).

Authors:  H Bocquet; M Bagot; J C Roujeau
Journal:  Semin Cutan Med Surg       Date:  1996-12

4.  Fulminant liver failure after vancomycin in a sulfasalazine-induced DRESS syndrome: fatal recurrence after liver transplantation.

Authors:  M Mennicke; A Zawodniak; M Keller; L Wilkens; N Yawalkar; F Stickel; A Keogh; D Inderbitzin; D Candinas; W J Pichler
Journal:  Am J Transplant       Date:  2009-09       Impact factor: 8.086

  4 in total
  1 in total

Review 1.  [Interstitial nephritis in rheumatic diseases].

Authors:  P Korsten; G A Müller
Journal:  Z Rheumatol       Date:  2015-05       Impact factor: 1.372

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.